Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, March 13, 2024
[ Wed, Mar 13th 2024
] - WOPRAI
[ Wed, Mar 13th 2024
] - WOPRAI
[ Wed, Mar 13th 2024
] - WOPRAI
[ Wed, Mar 13th 2024
] - WOPRAI
[ Wed, Mar 13th 2024
] - WOPRAI
[ Wed, Mar 13th 2024
] - WOPRAI
[ Wed, Mar 13th 2024
] - WOPRAI
[ Wed, Mar 13th 2024
] - WOPRAI
[ Wed, Mar 13th 2024
] - WOPRAI
[ Wed, Mar 13th 2024
] - WOPRAI
[ Wed, Mar 13th 2024
] - WOPRAI
[ Wed, Mar 13th 2024
] - WOPRAI
[ Wed, Mar 13th 2024
] - WOPRAI
[ Wed, Mar 13th 2024
] - WOPRAI
[ Wed, Mar 13th 2024
] - WOPRAI
[ Wed, Mar 13th 2024
] - WOPRAI
[ Wed, Mar 13th 2024
] - WOPRAI
[ Wed, Mar 13th 2024
] - WOPRAI
[ Wed, Mar 13th 2024
] - WOPRAI
Tue, March 12, 2024
[ Tue, Mar 12th 2024
] - WOPRAI
[ Tue, Mar 12th 2024
] - WOPRAI
[ Tue, Mar 12th 2024
] - WOPRAI
[ Tue, Mar 12th 2024
] - WOPRAI
[ Tue, Mar 12th 2024
] - WOPRAI
[ Tue, Mar 12th 2024
] - WOPRAI
[ Tue, Mar 12th 2024
] - WOPRAI
[ Tue, Mar 12th 2024
] - WOPRAI
[ Tue, Mar 12th 2024
] - WOPRAI
Derek Archila Upgraded (VTYX) to Buy and Increased Target to $16 on, Mar 12th, 2024
Derek Archila of Wells Fargo, Upgraded "Ventyx Biosciences, Inc." (VTYX) to Buy and Increased Target from $7 to $16 on, Mar 12th, 2024.
Derek has made no other calls on VTYX in the last 4 months.
There are 2 other peers that have a rating on VTYX. Out of the 2 peers that are also analyzing VTYX, 1 agrees with Derek's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Alex Thompson of "Stifel" Maintained at Hold with Decreased Target to $2 on, Monday, December 18th, 2023
This is the rating of the analyst that currently disagrees with Derek
- Edward Nash of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $16 on, Monday, March 11th, 2024
